Related Experiment Video
Updated: Jan 6, 2026

MitoCeption: Transferring Isolated Human MSC Mitochondria to Glioblastoma Stem Cells
Published on: February 22, 2017
Super mitochondria-enriched extracellular vesicles enable enhanced mitochondria transfer.
Yi Wang1, Hao-Yuan Yu1, Zi-Juan Yi1
1State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China.
Researchers enhanced mitochondria transfer by engineering mesenchymal stem cells (MSCs) to produce more extracellular vesicle-containing mitochondria (EV-Mito). This improved yield shows promise for treating mitochondrial diseases like Leber
Area of Science:
- Cell Biology
- Mitochondrial Biology
- Regenerative Medicine
Background:
- Mitochondria transfer is crucial for restoring function in damaged cells.
- Extracellular vesicles containing mitochondria (EV-Mito) are a key mechanism for this transfer.
- Current limitations in EV-Mito yield hinder therapeutic applications for mitochondrial diseases.
Purpose of the Study:
- To investigate the regulatory mechanism of EV-Mito release from mesenchymal stem cells (MSCs).
- To develop a method for increasing EV-Mito yield for enhanced therapeutic potential.
- To evaluate the efficacy of enhanced EV-Mito in a model of mitochondrial disease.
Main Methods:
- Identified a calcium-dependent pathway (CD38/IP3R/Ca2+) regulating EV-Mito release in MSCs.
- Utilized a non-viral gene engineering approach to activate this pathway, creating 'super donor' MSCs.
- Generated Super-EV-Mito with significantly increased yield compared to control EV-Mito.
- Tested Super-EV-Mito in a mouse model of Leber's hereditary optic neuropathy (LHON).
Main Results:
- Activation of the CD38/IP3R/Ca2+ pathway led to a threefold increase in EV-Mito yield.
- Super-EV-Mito successfully rescued mitochondrial DNA defects in the LHON mouse model.
- LHON-associated symptoms were alleviated in treated male mice.
- Demonstrated the potential of enhanced mitochondria transfer for treating mitochondrial disorders.
Conclusions:
- The CD38/IP3R/Ca2+ pathway is a key regulator of EV-Mito release from MSCs.
- Non-viral gene engineering can significantly enhance EV-Mito production.
- Super-EV-Mito represents a promising therapeutic strategy for mitochondrial diseases like LHON.
- This approach advances the clinical application of mitochondria transfer therapy.
More Related Videos
Related Concept Videos
Mitochondrial Membranes
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Intralumenal Vesicles and Multivesicular Bodies
Vesicular Tubular Clusters
With the help of motor proteins such...
Animal Mitochondrial Genetics

